Federated Hermes, Inc. Talaris Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.68 - $3.22 $895 - $1,075	-334 Reduced 12.44%	2,350 $6,000
Q2 2023 Aug 14, 2023	BUY	$1.78 - $3.2 $131 - $236	74 Added 2.84%	2,684 $8,000
Q1 2023 May 08, 2023	BUY	$1.09 - $2.09 $1,013 - $1,943	930 Added 55.36%	2,610 $4,000
Q4 2022 Feb 13, 2023	BUY	$0.94 - $1.64 $1,579 - $2,755	1,680 New	1,680 $1,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.